brand logo

Am Fam Physician. 2024;110(3):270-280

This clinical content conforms to AAFP criteria for CME.

Author disclosure: No relevant financial relationships.

Cushing's syndrome is a rare, multisystemic disease caused by chronic exposure to supraphysiologic levels of cortisol. Prolonged hypercortisolism is associated with significant multisystem morbidity and mortality and decreased quality of life. Diagnosis of Cushing's syndrome is often delayed by several years due to its insidiously progressive course, diverse clinical presentation, overlap of symptoms with many common conditions, and testing complexity. Exogenous glucocorticoid use must be excluded as the primary etiology. Excessive endogenous cortisol production can be caused by an overproduction of adrenocorticotropic hormone (ACTH) through pituitary tumors or ectopic sources (ACTH-dependent cases), or it can be caused by autonomous cortisol overproduction by the adrenal glands (ACTH-independent cases). The recommended diagnostic approach includes appropriate screening, confirmation of hypercortisolism, and determination of etiology. First-line treatment is surgical removal of the source of cortisol overproduction. Lifelong posttherapy monitoring is required to treat comorbidities and detect recurrence.

Cushing's syndrome is a multifaceted and progressive disease caused by chronic exposure to excessive levels of cortisol from iatrogenic or internal sources.110 Exogenous (iatrogenic) Cushing's syndrome, which is caused by the administration of glucocorticoids, is the most common form and must be ruled out.2,4,611 Endogenous Cushing's syndrome is classified as adrenocorticotropic hormone (ACTH) dependent (80% to 85% of cases) or ACTH independent (15% to 20% of cases; Table 11,2,8,10,1215). Most cases (75% to 80%) are caused by Cushing's disease, which features a pituitary adenoma excessively secreting ACTH.2,7,10,11 Endogenous Cushing's syndrome can also be caused by ectopic ACTH syndrome, which results from tumors that excessively produce ACTH (15% to 20% of cases) or corticotropin-releasing hormone (less than 1% of cases).2,10

Already a member/subscriber?  Log In

Subscribe

From $165
  • Immediate, unlimited access to all AFP content
  • More than 130 CME credits/year
  • AAFP app access
  • Print delivery available
Subscribe

Issue Access

$59.95
  • Immediate, unlimited access to this issue's content
  • CME credits
  • AAFP app access
  • Print delivery available

Article Only

$25.95
  • Immediate, unlimited access to just this article
  • CME credits
  • AAFP app access
  • Print delivery available
Purchase Access:  Learn More

Continue Reading

More in AFP

Copyright © 2024 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.